Home Online Features Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
Press Releases
Bora Pharmaceuticals Co., Ltd.  
October 25, 2024

Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals

TAIPEI, Taiwan, Oct. 25, 2024 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora" or "the Company", TWSE: 6472), today announced that its Board of Directors has approved the acquisition of US-based

logo salamanca press

Salamanca Press

email salamanca press
Local & Social